Internal Medicine, Hematology & Oncology · New York, NY
NPI
1114192242
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1233 York Ave, Sr 327
New York, NY, 10065
Phone (212) 639-4838
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
311 services
Medicare patients, 2024
71
Average age 67
Drug cost, 2024
$2.6M
743 prescriptions
Company payments, 2025
$47K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Doris M Ponce was code 99233 (hospital e&m - subsequent), 117 times for 20 patients. In total Doris M Ponce billed 311 services in 9 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 117 | 20 | $103.48 | $12K |
| 99215 Office E&M - Established | Office | 75 | 26 | $127.22 | $9,542 |
| 99214 Office E&M - Established | Office | 59 | 29 | $80.57 | $4,753 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $100.13 | $1,101 |
By year: 2022 $27K for 254 services; 2023 $46K for 444 services; 2024 $32K for 311 services.
Medicare prescription drug claims, 2024
In 2024, the drug Doris M Ponce prescribed most often to Medicare patients was Acyclovir, with 125 prescriptions and refills. In total Doris M Ponce wrote 743 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 125 | 218 | 29 | $1,862 |
| Rezurock Belumosudil Mesylate | 95 | 104 | 14 | $2.2M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 46 | 68 | 13 | $276 |
| Tacrolimus Generic | 33 | 33 | Under 11 | $542 |
| Prednisone Generic | 27 | 27 | 11 | $136 |
| Amlodipine Besylate Generic | 26 | 44 | Under 11 | $118 |
| Hydrocortisone Generic | 22 | 36 | Under 11 | $1,317 |
| Atovaquone Generic | 20 | 24 | Under 11 | $7,517 |
| Jakafi Ruxolitinib Phosphate | 19 | 19 | Under 11 | $282K |
| Ursodiol Generic | 19 | 25 | Under 11 | $1,306 |
| Montelukast Sodium Generic | 16 | 16 | Under 11 | $72.23 |
| Atorvastatin Calcium Generic | 16 | 18 | Under 11 | $97.82 |
| Losartan Potassium Generic | 15 | 35 | Under 11 | $111 |
| Omeprazole Generic | 12 | 16 | Under 11 | $59.56 |
| Penicillin V Potassium Generic | 12 | 12 | Under 11 | $57.02 |
Brand drugs: - claims; generic drugs: 592 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Doris M Ponce $47K ($47K in general payments such as food, travel and fees) from 7 companies. The largest payer was Incyte Corporation with $23K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.